The iconic rise of Viagra has consistently remained a example of pharmaceutical success, but its position within the broader sector now presents questions about future yields . Alternative versions are undercutting market share, prompting concerns that supporting companies heavily reliant to Viagra's once-dominant position could be a speculative st